Table 1 Comparison of demographics, comorbidities, and clinical manifestations of SFTS patients with pneumonia according to respiratory failure development.

From: A nomogram to predict respiratory failure development in severe fever with thrombocytopenia syndrome patients with pneumonia

 

No respiratory failure (n = 122)

Respiratory failure (n = 45)

P value

Demographics

 Male, n (%)

60(49.2)

18(56.3)

0.291

 Age (years)

64 ± 7

67 ± 7

0.094

Comorbidities, n (%)

 Diabetes mellitus

11(9.0)

9(20.0)

0.052

 Cardiovascular diseases

28(23.0)

12(26.7)

0.260

 Chronic pulmonary diseases

9(7.4)

7(15.6)

0.139

 Chronic liver diseases

9(7.4)

4(8.9)

0.750

Clinical manifestations, n (%)

 Neurological

  Coma

2(1.6)

6(13.3)

0.005

  Lethargy

4(3.3)

8(17.8)

0.003

  Confusion

3(2.5)

5(11.1)

0.034

  Dysphoria

2(1.6)

3(6.7)

0.122

  Convulsion

1(0.8)

2(4.4)

0.177

 Respiratory

  Cough

36(29.5)

21(46.7)

0.038

  Sputum

25(20.5)

19(42.2)

0.045

  Chest distress

31(25.4)

15(33.3)

0.309

  Dyspnea

15(12.3)

22(48.9)

< 0.001

 Gastrointestinal

  Anorexia

93(76.2)

42(93.3)

0.013

  Nausea

73(59.8)

30(66.7)

0.420

  Vomiting

43(35.2)

18(40.0)

0.571

  Abdominal pain

19(15.6)

17(37.7)

0.002

  Diarrhea

28(23.0)

15(33.3)

0.173

 Haemorrhagic

  Petechia and ecchymosis

9(7.4)

5(11.1)

0.529

  Haematemesis

4(3.3)

2(4.4)

0.661

  Melena

6(4.9)

3(6.7)

0.703

  Gingival bleeding

12(9.8)

7(15.6)

0.302

  Epistaxis

14(11.5)

8(17.8)

0.285

 Non-specific

  Fever > 38 °C

34(27.9)

18(40.0)

0.133

  Chills

25(20.5)

16(35.6)

0.045

  Headache

24(19.7)

8(17.8)

0.783

  Dizziness

48(39.3)

15(33.3)

0.477

  Myalgia

31(25.4)

17(37.7)

0.150